Recent News

• 12.08.2025 - Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri
• 11.17.2025 - FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5

Recent Filings

• 12.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.08.2025 - EX-99.1 EX-99.1
• 12.08.2025 - 3 Initial statement of beneficial ownership of securities
• 12.08.2025 - 8-K Current report
• 12.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 12.01.2025 - 144 Report of proposed sale of securities
• 12.01.2025 - 144 Report of proposed sale of securities
• 11.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 144 Report of proposed sale of securities